Neogen (NEOG) Competitors $5.00 +0.23 (+4.82%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$5.01 +0.01 (+0.18%) As of 08/7/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. HAE, XRAY, ICUI, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Haemonetics DENTSPLY SIRONA ICU Medical QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends. Is NEOG or HAE more profitable? Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -122.06%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-122.06% 2.39% 1.57% Haemonetics 12.32%26.37%9.22% Which has preferable valuation & earnings, NEOG or HAE? Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$894.66M1.21-$1.09B-$5.03-0.99Haemonetics$1.36B1.96$167.68M$3.3116.76 Do insiders & institutionals hold more shares of NEOG or HAE? 96.7% of Neogen shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 1.1% of Neogen shares are held by insiders. Comparatively, 1.8% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, NEOG or HAE? Neogen has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Do analysts rate NEOG or HAE? Neogen presently has a consensus price target of $7.50, suggesting a potential upside of 50.00%. Haemonetics has a consensus price target of $95.70, suggesting a potential upside of 72.48%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than Neogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Haemonetics 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media prefer NEOG or HAE? In the previous week, Neogen had 30 more articles in the media than Haemonetics. MarketBeat recorded 46 mentions for Neogen and 16 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.86 beat Neogen's score of 0.12 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 7 Very Positive mention(s) 2 Positive mention(s) 31 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Haemonetics 8 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHaemonetics beats Neogen on 15 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$10.44B$5.48B$9.57BDividend YieldN/A2.03%4.00%4.18%P/E Ratio-0.9919.2529.8825.14Price / Sales1.2123.33440.45103.02Price / Cash0.8321.8135.9458.58Price / Book0.522.848.105.59Net Income-$1.09B$211.77M$3.26B$265.48M7 Day Performance7.30%1.54%0.65%1.22%1 Month Performance-4.58%2.31%2.44%0.39%1 Year Performance-70.57%-11.48%27.59%23.47% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.9113 of 5 stars$5.00+4.8%$7.50+50.0%-69.5%$1.04B$894.66M-0.992,110Trending NewsGap UpHAEHaemonetics4.8489 of 5 stars$74.66-0.7%$97.30+30.3%-35.2%$3.59B$1.36B22.563,023Trending NewsEarnings ReportAnalyst ForecastGap DownXRAYDENTSPLY SIRONA4.6246 of 5 stars$16.07+0.2%$19.60+22.0%-44.0%$3.20B$3.79B-3.5414,000News CoverageEarnings ReportGap UpICUIICU Medical4.655 of 5 stars$127.50-1.8%$192.67+51.1%+6.7%$3.14B$2.38B-33.2915,000News CoveragePositive NewsQDELQuidelOrtho4.3647 of 5 stars$26.09-4.7%$44.33+69.9%-38.4%$1.76B$2.78B-5.256,600Trending NewsEarnings ReportAnalyst ForecastSTAASTAAR Surgical2.7385 of 5 stars$19.25+0.3%$18.00-6.5%-25.9%$953.45M$313.90M-13.371,211Trending NewsAnalyst ForecastCERSCerus2.8571 of 5 stars$1.36-2.2%$3.50+157.4%-40.7%$259.98M$180.27M-13.60290Positive NewsEarnings ReportOSUROraSure Technologies1.9009 of 5 stars$3.35-0.3%$3.00-10.4%-36.9%$250.58M$185.83M-7.98840News CoverageUTMDUtah Medical Products3.2584 of 5 stars$57.77-1.3%N/A-15.6%$190.17M$38.83M15.45180ANIKAnika Therapeutics4.5185 of 5 stars$11.33-1.5%$20.00+76.5%-68.3%$162.47M$119.91M-2.92300Positive NewsWSTWest Pharmaceutical Services4.5946 of 5 stars$257.36-2.3%$320.71+24.6%-18.0%$18.49B$2.89B38.5310,600Positive NewsGap Up Related Companies and Tools Related Companies HAE Competitors XRAY Competitors ICUI Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEOG Stock Alerts